Market Place
Sourcing Support
EnGeneIC launches new Australian trial for innovative cancer therapy
12 May 2025 //
GLOBENEWSWIRE
Oncologist Daniel Von Hoff Joins EnGeneIC Advisory Board
01 Oct 2024 //
GLOBENEWSWIRE
EnGeneIC, SingaporeMed Partner For Cancer Treatment Innovation In Asia
06 Jun 2024 //
GLOBENEWSWIRE
EnGeneIC granted Fast-Track Designation for ANDC Pancreatic Cancer Therapeutic
07 Dec 2023 //
GLOBENEWSWIRE
November is Pancreatic Cancer Awareness Month
08 Nov 2023 //
GLOBENEWSWIRE
EnGeneIC publishes the COVID-EDV vaccine"s novel mechanism of action
31 Jan 2023 //
GLOBENEWSWIRE
EnGeneIC’s Covid-19 vaccine offers protection against variants in trials
30 Jun 2022 //
CLINICALTRIALSARENA
EnGeneIC’s second generation COVID-19 vaccine protects against all variants
28 Jun 2022 //
GLOBENEWSWIRE
Sciwind gets licensing deal with Sanofi for metabolic disease candidates
30 Nov 2021 //
ENDPTS
EnGeneIC, develops world-first nanocellular anti-COVID-19 vaccine
07 Sep 2021 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.